Christopher S. Boerner
Chief Executive Officer, Bristol-Myers Squibb.
Companies
- Colgate-Palmolive CompanyBoard member Mar 24, 2026 to now1
- Bristol-Myers SquibbBoard member Mar 12, 2024 to now2
- Bristol-Myers SquibbChief executive officer Nov 3, 2023 to now3
- Bristol-Myers SquibbEVP, Chief Commercial Officer Sep 6, 2018 to Mar 14, 20234
- SeagenSVP, Commercial Mar 5, 2012 to Aug 27, 20145
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bristol-Myers Squibb BMY146,890 shares6$9.0M at $60.95Mar 12, 2026
Colgate-Palmolive Company CL1,383 shares7$129.0K at $93.26May 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 11, 2026Granted 1,383 shares of Colgate-Palmolive Company7
- Mar 10, 2026Shares withheld for tax 4,632 shares at $60.13 of Bristol-Myers Squibb6
- Mar 10, 2026Other 8,734 shares of Bristol-Myers Squibb6
- Mar 10, 2026Exercised options 17,788 shares of Bristol-Myers Squibb6
- Mar 10, 2026Shares withheld for tax 10,518 shares at $60.13 of Bristol-Myers Squibb6
- Mar 10, 2026Other 19,835 shares of Bristol-Myers Squibb6
- Mar 10, 2026Exercised options 40,398 shares of Bristol-Myers Squibb6
- Mar 10, 2026Shares withheld for tax 3,073 shares at $60.13 of Bristol-Myers Squibb6
- Mar 10, 2026Other 727 shares of Bristol-Myers Squibb6
- Mar 10, 2026Exercised options 6,733 shares of Bristol-Myers Squibb6
- Mar 10, 2026Shares withheld for tax 3,006 shares at $60.13 of Bristol-Myers Squibb6
- Mar 10, 2026Other 743 shares of Bristol-Myers Squibb6
- Mar 10, 2026Exercised options 6,618 shares of Bristol-Myers Squibb6
- Nov 1, 2025Shares withheld for tax 1,238 shares at $46.07 of Bristol-Myers Squibb8
- Nov 1, 2025Other 544 shares of Bristol-Myers Squibb8
- Nov 1, 2025Exercised options 2,964 shares of Bristol-Myers Squibb8
- Jun 13, 2025Gift 62,719 shares of Bristol-Myers Squibb9
- Jun 13, 2025Gift 62,719 shares of Bristol-Myers Squibb9
- Jun 3, 2025Gift 62,720 shares of Bristol-Myers Squibb10
- Jun 3, 2025Gift 62,720 shares of Bristol-Myers Squibb10
- Mar 10, 2025Shares withheld for tax 12,818 shares at $63.11 of Bristol-Myers Squibb11
- Mar 10, 2025Other 14,641 shares of Bristol-Myers Squibb11
- Mar 10, 2025Exercised options 39,700 shares of Bristol-Myers Squibb11
- Mar 10, 2025Shares withheld for tax 2,858 shares at $63.11 of Bristol-Myers Squibb11
- Mar 10, 2025Other 1,147 shares of Bristol-Myers Squibb11
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | BMY | Buy | $110.1K | +7.1% | −19.3% | −4.2% |
| Dec 5, 2023 | BMY | Buy | $99.6K | +19.0% | −50.1% | −16.9% |
| Nov 28, 2023 | BMY | Buy | $150.0K | +22.1% | −47.5% | −10.5% |
| Mar 14, 2022 | BMY | Sale | $2.0M | −13.7% | +98.8% | −2.1% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARBristol-Myers Squibb, Board member
- 3
- 4
- 5SEC EDGARSeagen, SVP, Commercial
- 6
- 7
- 8SEC EDGARForm 4 filed Nov 4, 2025
- 9SEC EDGARForm 4 filed Jun 16, 2025
- 10SEC EDGARForm 4 filed Jun 4, 2025
- 11SEC EDGARForm 4 filed Mar 12, 2025